Spectrum Wealth Advisory Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4K Buy
+16
New +$3.45K ﹤0.01% 283
2022
Q3
Sell
-1,814
Closed -$246K 39
2022
Q2
$246K Sell
1,814
-298
-14% -$41.1K 0.27% 34
2022
Q1
$315K Sell
2,112
-13,910
-87% -$2.06M 0.3% 36
2021
Q4
$2.6M Buy
16,022
+214
+1% +$34.6K 2.31% 14
2021
Q3
$2.63M Buy
15,808
+64
+0.4% +$10.9K 2.59% 12
2021
Q2
$2.72M Sell
15,744
-5,857
-27% -$967K 2.66% 12
2021
Q1
$3.47M Buy
21,601
+6,616
+44% +$1.13M 3.31% 9
2020
Q4
$2.52M Sell
14,985
-13,615
-48% -$2.21M 2.84% 11
2020
Q3
$4.45M Buy
28,600
+14,652
+105% +$2.4M 2.85% 11
2020
Q2
$2.34M Buy
13,948
+2,239
+19% +$351K 3.3% 9
2020
Q1
$1.52M Sell
11,709
-303
-3% -$43.2K 3.29% 10
2019
Q4
$1.79M Buy
12,012
+621
+5% +$85.3K 3.2% 8
2019
Q3
$1.41M Buy
11,391
+2,045
+22% +$272K 2.8% 13
2019
Q2
$1.3M Buy
+9,346
New +$1.29M 2.67% 13

Other funds holding FBT

Spectrum Wealth Advisory Group's FBT Position: Q2 2026 in Review

Spectrum Wealth Advisory Group opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 16 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #283 among its holdings. This is a return to the name: Spectrum Wealth Advisory Group previously reported a position in FBT as recently as Q2 2022.

Spectrum Wealth Advisory Group first reported a position in FBT in Q2 2019 and has held it in 14 quarters since. The position peaked at $4.45M in Q3 2020. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Spectrum Wealth Advisory Group held 16 shares of First Trust NYSE Arca Biotechnology Index Fund worth $4K as of Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Spectrum Wealth Advisory Group position in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Spectrum Wealth Advisory Group's portfolio in Q2 2026, its #283 holding.
  • Spectrum Wealth Advisory Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2019 and has held it in 14 quarters since.
  • Spectrum Wealth Advisory Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4.45M in Q3 2020.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Spectrum Wealth Advisory Group's 13F filing for Q2 2026, filed 6 Aug 2026.